Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy
- PMID: 2167103
- DOI: 10.1097/00002030-199006000-00014
Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy
Abstract
We demonstrate for the first time the appearance of acyclovir resistance in serial varicella zoster isolates from a patient treated with acyclovir. We recovered varicella zoster virus three times over a period of 5 months from the skin lesions of this patient with AIDS who was treated with three courses of intravenous acyclovir and prolonged low-dose oral acyclovir. The isolate recovered from a typical zoster lesion before acyclovir, and one obtained from a hyperkeratotic lesion 2 months later, after intravenous and oral acyclovir, were sensitive to acyclovir and produced normal amounts of thymidine kinase. In contrast, virus recovered from lesions 5 months after the onset, when the patient had received repeated courses of acyclovir, was acyclovir-resistant and thymidine-kinase-deficient. Resistance to acyclovir was associated with persistence of lesions which failed to improve with intravenous acyclovir, but was not associated with new lesion formation.
Similar articles
-
Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome.Arch Dermatol. 1990 Aug;126(8):1048-50. Arch Dermatol. 1990. PMID: 2166483
-
Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).Ann Intern Med. 1990 Feb 1;112(3):187-91. doi: 10.7326/0003-4819-112-3-187. Ann Intern Med. 1990. PMID: 2297195
-
Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.J Med Virol. 1998 Jul;55(3):250-4. J Med Virol. 1998. PMID: 9624615
-
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):254-60. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8106965 Review.
-
Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.J Antimicrob Chemother. 1983 Sep;12 Suppl B:169-79. doi: 10.1093/jac/12.suppl_b.169. J Antimicrob Chemother. 1983. PMID: 6313596 Review.
Cited by
-
Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures.Eur J Med Chem. 2017 Jan 27;126:84-100. doi: 10.1016/j.ejmech.2016.10.002. Epub 2016 Oct 4. Eur J Med Chem. 2017. PMID: 27750154 Free PMC article.
-
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.Clin Microbiol Rev. 1994 Jan;7(1):1-13. doi: 10.1128/CMR.7.1.1. Clin Microbiol Rev. 1994. PMID: 8118786 Free PMC article. Review.
-
Varicella zoster virus infection.Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16. Nat Rev Dis Primers. 2015. PMID: 27188665 Free PMC article. Review.
-
In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.J Virol. 2012 Mar;86(5):2641-52. doi: 10.1128/JVI.06620-11. Epub 2011 Dec 21. J Virol. 2012. PMID: 22190713 Free PMC article.
-
A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.Antimicrob Agents Chemother. 2000 Apr;44(4):873-8. doi: 10.1128/AAC.44.4.873-878.2000. Antimicrob Agents Chemother. 2000. PMID: 10722484 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical